| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,500,000 |
| Market
Cap: |
2.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$38.65 - $65 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amphastar Pharmaceuticals is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing and selling generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient (API) products. Co.'s reportable segments are: finished pharmaceutical products, which manufactures, markets and distributes Primatene Mist®, glucagon, enoxaparin, naloxone, phytonadione, lidocaine, epinephrine, various critical and non-critical care drugs; and API, which manufactures and distributes recombinant human insulin API and porcine insulin API for external customers and internal product development.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
32,136 |
396,652 |
637,244 |
1,063,187 |
| Total Sell Value |
$1,498,005 |
$22,240,305 |
$34,650,077 |
$50,026,056 |
| Total People Sold |
3 |
6 |
9 |
11 |
| Total Sell Transactions |
5 |
14 |
31 |
71 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-18 |
4 |
AS |
$18.58 |
$7,562 |
I/I |
(407) |
6,827,679 |
|
11% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-17 |
4 |
AS |
$18.67 |
$257,723 |
I/I |
(13,801) |
6,828,086 |
|
11% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-16 |
4 |
AS |
$18.51 |
$301,031 |
I/I |
(16,259) |
6,841,887 |
|
14% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-12 |
4 |
AS |
$18.94 |
$251,522 |
I/I |
(13,277) |
6,858,146 |
|
11% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-11 |
4 |
AS |
$19.06 |
$377,884 |
I/I |
(19,823) |
6,871,423 |
|
6% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-10 |
4 |
AS |
$18.76 |
$295,344 |
I/I |
(15,747) |
6,891,246 |
|
7% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-09 |
4 |
AS |
$18.93 |
$225,776 |
I/I |
(11,927) |
6,906,993 |
|
7% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-08 |
4 |
AS |
$18.89 |
$254,049 |
I/I |
(13,452) |
6,918,920 |
|
7% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO, Chief Scientist & Chairma |
– – • |
2021-02-05 |
4 |
AS |
$18.94 |
$293,721 |
I/I |
(15,507) |
6,932,372 |
|
7% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-04 |
4 |
AS |
$18.89 |
$483,020 |
I/I |
(25,570) |
6,947,879 |
|
6% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-03 |
4 |
AS |
$18.36 |
$299,323 |
I/I |
(16,299) |
6,973,449 |
|
8% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-02 |
4 |
AS |
$18.66 |
$257,821 |
I/I |
(13,817) |
6,989,748 |
|
6% |
|
| Applied Physics & Chemistry Laboratories, Inc. |
COO,Chief Scientist & Chairman |
– – • |
2021-02-01 |
4 |
AS |
$18.29 |
$441,120 |
I/I |
(24,114) |
7,003,565 |
|
8% |
|
| Petersen Floyd F. |
Director |
– • – |
2021-02-01 |
4 |
AS |
$18.26 |
$11,669 |
D/D |
(639) |
73,354 |
|
8% |
|
| Peters William J |
CFO, SVP & Treasurer |
• – – |
2021-01-19 |
4 |
AS |
$18.67 |
$121,237 |
D/D |
(6,495) |
89,548 |
|
2% |
|
| Petersen Floyd F. |
Director |
– • – |
2020-12-01 |
4 |
AS |
$17.87 |
$8,936 |
D/D |
(500) |
73,993 |
|
-3% |
|
| Petersen Floyd F. |
Director |
– • – |
2020-11-02 |
4 |
AS |
$19.84 |
$9,920 |
D/D |
(500) |
74,493 |
|
-4% |
|
| Petersen Floyd F. |
Director |
– • – |
2020-10-01 |
4 |
AS |
$18.89 |
$9,446 |
D/D |
(500) |
74,993 |
|
1% |
|
| Petersen Floyd F. |
Director |
– • – |
2020-09-01 |
4 |
AS |
$19.90 |
$9,948 |
D/D |
(500) |
75,493 |
|
-2% |
|
| Peters William J |
CFO, SVP & Treasurer |
• – – |
2020-08-14 |
4 |
AS |
$20.36 |
$112,223 |
D/D |
(5,512) |
95,652 |
|
-6% |
|
| Maris David |
Director |
– • – |
2020-08-14 |
4 |
B |
$20.26 |
$20,260 |
D/D |
1,000 |
13,151 |
2.39 |
-6% |
|
| Prins Richard K |
Director |
– • – |
2020-08-11 |
4 |
S |
$20.33 |
$121,976 |
D/D |
(6,000) |
39,160 |
|
5% |
|
| Petersen Floyd F. |
Director |
– • – |
2020-08-03 |
4 |
AS |
$20.62 |
$10,308 |
D/D |
(500) |
75,993 |
|
-9% |
|
| Liawatidewi Yakob |
EVP Corp Admin Center |
• – – |
2020-07-21 |
4 |
AS |
$21.22 |
$126,837 |
D/D |
(5,978) |
45,996 |
|
-16% |
|
| Liawatidewi Yakob |
EVP Corp Admin Center |
• – – |
2020-07-21 |
4 |
OE |
$11.33 |
$67,731 |
D/D |
5,978 |
51,974 |
|
- |
|
955 Records found
|
|
Page 13 of 39 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.14 (2.76%) 
